Dalotuzumab
From Infogalactic: the planetary knowledge core
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Humanized (from mouse) |
| Target | IGF-1 receptor |
| Identifiers | |
| CAS Number | 1005389-60-5  |
| ATC code | none |
| UNII | 6YI1L648RH  |
| Chemical data | |
| Formula | C6528H10086N1730O2018S40 |
| Molecular mass | 146.4 kg/mol |
| (what is this?) (verify) |
|
Dalotuzumab is a humanized monoclonal antibody designed for the treatment of cancers.[1]
Dalotuzumab was developed by Merck & Co., Inc.
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it. |
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
Categories:
- Chemical articles having calculated molecular weight overwritten
- Drugs that are a monoclonal antibody
- Articles without EBI source
- Chemicals that do not have a ChemSpider ID assigned
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Merck
- Monoclonal antibody stubs
- Antineoplastic and immunomodulating drug stubs
